An Evaluation of Simvastatin 20 mg Plus Omacor [omega-3 ethylester concentrate] 4 g Compared to Simvastatin 20 mg Plus Placebo in Subjects With Mixed Dyslipidemia.
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 02 Jun 2011
At a glance
- Drugs Omega-3-acid ethyl esters; Simvastatin
- Indications Dyslipidaemias; Hyperlipoproteinaemia type V
- Focus Therapeutic Use
- 15 Aug 2008 Primary endpoint 'Non high density lipoprotein cholesterol' has been met.
- 16 Jul 2007 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History